Sanofi & Regeneron’s Dupixent pivotal study meets all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis: Paris Monday, November 10, ...

Positive top-line results from VIBRANT Phase 2 trial of verekitug in CRSwNP reported in September showed statistically ...

Phase 3 data to be presented at ACAAI demonstrate Dupixent significantly reduced key nasal signs and symptoms including sinus opacification, ...

Dinesh Madhok, MD, gastroenterologist CEO of Jacksonville, Fla.-based Borland Groover, joined Becker’s to discuss the three biggest challenges facing gastroenterology practices today. Dr. Madhok was ...

A survey shows a desire to take more sedation responsibility back from anesthesiologists and certified nurse anesthetists.

UT Health San Antonio has begun offering endoscopic submucosal dissection, a minimally invasive technique for removing early-stage colorectal lesions without surgery.  The procedure is performed using ...

Dupixent sBLA accepted for priority review by the US FDA with a target action date of February 28, 2026; if approved, Dupixent would be the first and only medicine indicated specifically for AFRS, ...

Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-powered healthcare and specialty pharma, today announced that ColonPRO EU, the Company’s next-generation artificial intelligence software ...

The Family Health Care Institute bulletin (one of King Hussein Foundation's institutes), on this Sunday, discusses nasal and ...

Cold air, dust and autumn walks can turn a harmless atchoo into a nagging puzzle for worried dog owners. A quick sneeze now ...

IRELAND’S FREE BOWEL cancer screening programme is now available to men and women from age 58 to 70. The HSE programme, ...

The commission ordered the hospital and doctors to pay Rs 7,16,100 to cover his medical bills and compensate him for the pain ...